# Efficacy and Safety of Dexlansoprazole on Heartburn Relief in Chinese Patients

> **NCT02873689** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 217 (actual)

## Conditions studied

- Heartburn
- Gastroesophageal Reflux Disease

## Interventions

- **DRUG:** Dexlansoprazole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02873689
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-27
- **Primary completion:** 2018-03-14
- **Final completion:** 2018-04-19
- **Target enrollment:** 217 (ACTUAL)
- **Last updated:** 2019-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02873689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02873689, "Efficacy and Safety of Dexlansoprazole on Heartburn Relief in Chinese Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02873689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*